This page includes the latest FDA filings for Acura Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | OTHER OTC Market | ACUR | DUNS 001315530 |
Device Company | Device | Date |
---|---|---|
Acura Pharmaceuticals, Inc., Patheon Pharmaceuticals, Inc. | Otc Medication | 2020-07-15 |
Acura Pharmaceuticals, Inc. | Nexafed | 2020-07-10 |
Acura Pharmaceuticals, Inc., Patheon Pharmaceuticals, Inc. | Otc Medication | 2012-12-10 |
NCAGE Code | 6ZMA1 | ACURA PHARMACEUTICALS, INC. |
CAGE Code | 6ZMA1 | ACURA PHARMACEUTICALS, INC. |
S.A.M. Registration | 6ZMA1 [1315530] | ACURA PHARMACEUTICALS, INC. |
SEC | 0000786947 | ACURA PHARMACEUTICALS, INC of NEW YORK |